NLM Digital Collections

Search

Start Over Formats Text ✖Remove constraint Formats: Text Subjects Child ✖Remove constraint Subjects: Child

91. Implementing national health reform in California: changes to public and private insurance

Publication:
[Oakland, Calif.] : California HealthCare Foundation, c2010
Subject(s):
Health Care Reform -- legislation & jurisprudence
Insurance Coverage -- legislation & jurisprudence
Insurance, Health -- legislation & jurisprudence
Private Sector -- legislation & jurisprudence
Public Sector -- legislation & jurisprudence
Child
Child Health Services
Eligibility Determination
Health Care Reform -- economics
Insurance Benefits
Insurance Coverage -- economics
Insurance, Health -- economics
Managed Care Programs -- economics
Managed Care Programs -- legislation & jurisprudence
Private Sector -- economics
Public Sector -- economics
State Health Plans -- legislation & jurisprudence
Humans
California
United States
United States.

93. E11(R1) addendum: clinical investigation of medicinal products in the pediatric population

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, April 2018
Subject(s):
Clinical Trials as Topic -- ethics
Drug Compounding -- standards
Pediatrics
Pharmaceutical Preparations
Child
Excipients
Infant
Infant, Newborn
International Cooperation
Models, Theoretical
Pharmaceutical Preparations -- administration & dosage
Taste
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

94. Anthrax: developing drugs for prophylaxis of inhalational anthrax

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, May 2018
Subject(s):
Anthrax -- drug therapy
Anthrax -- prevention & control
Antibiotic Prophylaxis
Clinical Trials as Topic
Drug Evaluation, Preclinical -- standards
Drugs, Investigational -- therapeutic use
Inhalation Exposure
Adult
Child
Endpoint Determination
Microbial Sensitivity Tests -- standards
Pediatrics
Product Surveillance, Postmarketing -- standards
Research Design
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

95. Clarification of orphan designation of drugs and biologics for pediatric subpopulations of common diseases

Publication:
Silver Spring, MD : Office of Orphan Products Development, Food and Drug Administration, July 2018
Subject(s):
Drug Approval
Orphan Drug Production
Pediatrics
Adolescent
Biological Products
Child
Clinical Trials as Topic
Colitis, Ulcerative -- drug therapy
HIV Infections -- drug therapy
Infant
Prevalence
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

96. Allergic rhinitis: developing drug products for treatment

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2018
Subject(s):
Clinical Trials as Topic
Drug Evaluation
Rhinitis, Allergic -- drug therapy
Adrenal Cortex Hormones -- therapeutic use
Adult
Child
Drug Combinations
Research Design
Single-Blind Method
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

99. The Medi-Cal prescription drug benefit: an overview

Publication:
Oakland, Calif. : California HealthCare Foundation, [2009]
Subject(s):
Health Expenditures -- trends
Insurance Benefits
Insurance, Pharmaceutical Services
Medicaid
Prescription Drugs -- economics
Adult
Aged
Child
Cost Control
Cost Sharing
Disabled Persons
Drug Costs
Drug Utilization Review
Drugs, Generic
Fee-for-Service Plans
Forecasting
Managed Care Programs
Medicare Part D
Middle Aged
Humans
California